Exelon, Rivastigmine News

Love as effective as medicine for Alzheimer's? Researchers have found evidence that the physical and mental decline of Alzheimer's patients was slower for patients who have a close relationship with their caregivers.

People taking one of several drugs commonly prescribed to treat Alzheimer's disease are more likely to be hospitalized for a potentially serious condition called bradycardia than patients not taking these medications.

The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.

The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.

The following is extracted from a letter written to the National Health Fund on May 25, 2009, by Dr Loraine Barnaby while she was consultant psychiatrist in the Dementia Clinic at the University Hospital of the West Indies.

NEW Abstract A straightforward chemoenzymatic synthesis of enantiomerically pure rivastigmine has been efficiently carried out under mild reaction conditions, with Candida antarctica lipase B responsible for the stereoselective acetylation of the corresponding -alcohol or amine.

Medication can improve the quality of life for people with Alzheimer's and their caregivers.

The protracted battle in the UK over access to Alzheimer's drugs has finally ended, with the National Institute for Health and Clinical Excellence issuing its final technology appraisal for the medicines, which was updated in the light of the court case against Eisai and Pfizer, manufacturers and distributors of Aricept .